Adma Biologics reported $222.1M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Adma Biologics USD 222.1M 15.63M Mar/2026
Alnylam Pharmaceuticals USD 200.15M 117.43M Mar/2026
BioCryst Pharmaceuticals USD 5.98M 587K Mar/2026
Novavax USD 11.46M 87K Mar/2026
Omeros USD 712K 266K Sep/2021
Takeda JPY 1.41T 107.71B Dec/2025